Catherine Garnett
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Intensity of conditioning but not measurable residual disease status affects the outcomes of umbilical cord blood transplantation.
Journal: Blood advances
Published: October 01, 2025
Intensity of conditioning but not measurable residual disease status impacts the outcomes of umbilical cord blood transplantation.
Journal: Blood advances
Published: October 01, 2025
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome.
Journal: Blood
Published: March 18, 2025
Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust.
Journal: Leukemia & lymphoma
Published: September 02, 2021
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.
Journal: Leukemia & lymphoma
Published: November 10, 2020
Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Journal: Haematologica
Published: June 13, 2020
Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: A case report.
Journal: British journal of haematology
Published: June 10, 2020
GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome.
Journal: IUBMB life
Published: August 15, 2019
Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia.
Journal: Blood advances
Published: August 23, 2016
Last Updated: 09/26/2026